Target Audience: Scientists and clinicians interested in initiating and executing investigator-initiated biomarker trials.
Date: October 29, 2024
Time: 14:15 - 18:15
Location: Biomedicum 1, Lecture Hall 2
Registration:
Register here by October 25th, 2024
14:15 Opening Remarks
14:20-14:45 Example of a Successful Biomarker Trial
Speaker: Sirpa Leppä, HUS and UH
Navigating Regulatory Terrain:
14:45-15:15 Concepts and principles of clinical drug trials
Speaker: Janne Backman, HUS and UH
15:15-15:45: Performance Evaluation and Performance Studies of In vitro Diagnostics Medical Devices on Regulation Perspective
Speaker: Hanna Valo, Fimea
15:45-16:00 Networking Break: Refreshments Served
Spotlight on Biomarker-Driven Trials:
16:00-16:10 From basic science to head and neck cancer precision diagnostics; the EPLINEx story
Speaker: Jukka Westermark, Turku Bioscience Centre, University of Turku & Åbo Akademi
16:10-16:20 A common variant in MNTR1B affects melatonin response – example of a genotype-based case-control study
Speaker: Tiinamaija Tuomi, HUS and FIMM
16:20-16:40 Insights from the Finprove Initiative
Speaker: Katriina Jalkanen, HUS
16:40-17:00 Companion diagnostic development in oncology: matching patients and drugs
Speaker: Caroline Heckman, FIMM
17:00-17:30 Panel Discussion featuring all speakers
17:30-18:15 Networking Reception: Cheese and Wine with the Speakers
Organised by Institute for Molecular Medicine Finland FIMM, HiLIFE, University of Helsinki. Organising committee: Anniina Färkkilä, Caroline Heckman, Mika Kontro, Tiinamaija Tuomi